Abstract
The pathophysiology of cough variant asthma is poorly understood. In particular, the mechanisms that cause different symptoms in typical asthma (in which wheeze predominates) compared with cough variant asthma (in which cough predominates) have not been determined. Traditional explanations include higher wheezing thresholds, differences in cough sensitivity, and/or differences in small airway function. Recent studies using high-dose methacholine challenge testing suggest that altered small-airway function plays a role. Preservation or loss of the bronchoprotective effect of a deep inspiration may be a fundamental pathophysiologic difference between asthma, cough variant asthma, methacholine-induced cough with normal sensitivity, and eosinophilic bronchitis.
Similar content being viewed by others
References
Glauser FL (1972) Variant asthma. Ann Allergy 30(8):457–459
Corrao WM, Braman SS, Irwin RS (1979) Chronic cough as the sole presenting manifestation of bronchial asthma. New Engl J Med 300:633–637
Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV et al (2006) Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 129(1):1S–23S
Turcotte SE, Lougheed MD (2011) Cough in asthma. Curr Opin Pharmacol 11(3):231–237
Irwin RS, French CT, Smyrnios NA, Curley FJ (1997) Interpretation of positive results of a methacholine inhalation challenge and 1 week inhaled bronchodilator use in diagnosing cough variant-asthma. Arch Intern Med 157(17):1981–1987
Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE (1989) Chronic cough: eosinophilic bronchitis without asthma. Lancet 1(8651):1346–1348
McGarvey L, Morice AH, Fujimura M, Ogawa H (2003) Atopic cough: little evidence to support a new clinical entity. Thorax 58:736–773a
Fujimura M, Sakamoto S, Matsuda T (1992) Bronchodilator-resistive cough in atopic patients: bronchial reversibility and hyperresponsiveness. Intern Med 31(4):447–452
Woolcock AJ, Salome CM, Yan K (1984) The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis 130:71–75
Sterk PJ, Daniel EE, Zamel N, Hargreae FE (1985) Limited bronchoconstriction to methacholine using partial flow-volume curves in nonasthmatic subjects. Am Rev Respir Dis 132:272–277
Sterk PJ, Daniel EE, Zamel N, Hargreave FE (1985) Limited maximal airway narrowing in nonasthmatic subjects. Am Rev Respir Dis 132:865–870
Irwin RS, Corrao WM, Pratter MR (1981) Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 123(4 Pt 1):413–417
Irwin RS, Boulet LP, Cloutier MM, Fuller R, Gold PM, Hoffstein V, Ing AJ, McCool FD, O’Byrne P, Poe RH et al (1998) Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American college of chest physicians. Chest 114(2):133S–181S
American Thoracic Society (2000) Guidelines for methacholine and exercise challenge testing—1999. Am J Respir Crit Care Med 161:309–329
Pratter MR, Bartter T, Akers S, Dubois J (1993) An algorithmic approach to chronic cough. Ann Intern Med 119(10):977–983
Fujimura M, Ogawa H, Nishizawa Y, Nishi K (2003) Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? Thorax 58:14–18
Dicpinigaitis PV (2004) Cough: cough in asthma and eosinophilic bronchitis. Thorax 59:71–72
Koh YY, Park Y, Kim CK (2002) The importance of maximal airway response to methacholine in the prediction of wheezing development in patients with cough-variant asthma. Allergy 57(12):1165–1170
Lougheed MD, Lam M, Forkert L, Webb KA, O’Donnell DE (1993) Breathlessness during acute bronchoconstriction in asthma: pathophysiologic mechanisms. Am Rev Respir Dis 148:1452–1459
Lougheed MD, Webb KA, O’Donnell DE (1995) Breathlessness during induced lung hyperinflation in asthma: the role of the inspiratory threshold load. Am J Respir Crit Care Med 152:911–920
Lougheed MD, O’Donnell DE (2005) Dyspnea in asthma. In: Mahler DA, O’Donnell DE (eds) Dyspnea: mechanisms, measurement and management lung biology in health and disease, vol 208, 2nd edn. Taylor and Francis Group, Boca Raton, pp 59–86
Lougheed MD, Fisher T, O’Donnell DE (2006) Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception. Chest 130(4):1072–1081
Woolcock A, Read J (1966) Lung volumes in exacerbations of asthma. Am J Med 41:259–273
Chen RC, Yan S (1999) Perceived inspiratory difficulty during inspiratory threshold and hyperinflationary loadings. Am J Respir Crit Care Med 159:720–727
Yan S (1999) Sensation of inspiratory difficulty during inspiratory threshold and hyperinflationary loadings: effect of inspiratory muscle strength. Am J Respir Crit Care Med 160:1544–1549
Yan S, Bates JH (1999) Breathing responses to small inspiratory threshold loads in humans. J Appl Physiol 86:874–880
Permutt S (1973) Physiological changes in the acute asthmatic attack. In: Austen KF, Licheister LM (eds) Asthma: physiology, immunopharmacology and treatment. Academic Press, New York, pp 15–27
Permutt S, Fessler HE, Brower RG, Kosnik E (1992) Breathlessness in acute asthma. In: Breathlessness: the Campbell symposium. Norman L. Jones, Hamilton, pp 60–65
Matsumoto H, Niimi A, Takemura M, Ueda T, Yamaguchi M, Matsuoka H, Jinnai M, Chin K, Mishima M (2009) Features of cough variant asthma and classic asthma during methacholine-induced brochoconstriction: a cross-sectional study. Cough 5:3
Kang H, Koh YY, Yoo Y, Yu J, Kim DK, Kim CK (2005) Maximal airway response to methacholine in cough-variant asthma: comparison with classic asthma and its relationship to peak expiratory flow variability. Chest 128(6):3881–3887
Lougheed MD, Fisher T (2007) Physiology of cough in asthma: mechanical responses to high-dose methacholine. Am J Respir Crit Care Med 175:A343
Lougheed MD, Dostaler SM, Fisher T (2009) Methacholine-induced dynamic hyperinflation and gas trapping: a variant of cough variant asthma? Am J Respir Crit Care Med 179:5764
King GC, Moore BJ, Seow CY, Pare PD (2001) Airway narrowing associated with inhibition of deep inspiration during methacholine inhalation in asthmatics. Am J Respir Crit Care Med 164:216–218
Skloot G, Permutt S, Togias A (1995) Airway responsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest 96:2393–2403
Moore BJ, Verburgt LM, King GG, Pare PD (1997) Effect of deep inspiration on methacholine dose–response curves in normal subjects. Am J Respir Crit Care Med 156:1278–1281
Burns CB, Taylor WR, Ingram RH Jr (1985) Effects of deep inhalation in asthma. Relative airway and parenchymal hysteresis. J Appl Physiol 59:1590–1596
Fisher JT, Canning BJ (2011) Cough and dyspnea—taking your breath away. Curr Opin Pharmacol 11(3):193–194
Acknowledgments
The authors thank Ms. Caroline Hensman, MLT, Kingston General Hospital, Kingston, Canada, for processing sputum samples, and Dr. Charles Leduc, Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Canada, for his assistance in obtaining the photomicrograph of sputum eosinophilia.
Conflict of interest
The research studies discussed in this review were funded by The Ontario Thoracic Society of the Ontario Lung Association, Physicians’ Services Incorporated Foundation, and the Queen’s University’s William Spear/Start Memorial Fund. In the past three years, MD Lougheed’s research has been funded by Queen’s University (William M. Spear Endowment/Start Memorial Fund), the Government of Ontario (Asthma Plan of Action), AllerGen Network for Centres of Excellence, the Ontario Lung Association/Ontario Thoracic Society, Canadian Institutes of Health Research (CIHR), and the Canadian Cystic Fibrosis Foundation. Pharmaxis Ltd. has provided dry powder mannitol (Aridol®) for research funded by Queen’s University and the Ontario Lung Association. S. E. Turcotte has received an Ontario Graduate Scholarship and a CIHR Canada Graduate Scholarship Master’s Award. M. D. Lougheed has been a site investigator for multicentre clinical trials funded by Ception Therapeutics Inc., MedImmune, and MPEX Pharmaceuticals. S. E. Turcotte and A. T. Fisher have no conflicts of interest or financial ties to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lougheed, M.D., Turcotte, S.E. & Fisher, T. Cough Variant Asthma: Lessons Learned from Deep Inspirations. Lung 190, 17–22 (2012). https://doi.org/10.1007/s00408-011-9348-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-011-9348-6